Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Diamandis

Showing results (291-300 of 787) with videos related to

Pageof 79
Sort By:
Journal of Proteome Research|June 15, 2007
Proteomic analysis of human cervico-vaginal fluidJulie L V Shaw, Christopher R Smith, Eleftherios P Diamandis
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2011
Immuno-mass spectrometry: quantification of low-abundance proteins in biological fluidsVathany Kulasingam, Christopher R Smith, Ihor Batruch, et al.
Clinical Chemistry|November 2, 1999
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSAA Magklara, A Scorilas, W J Catalona, et al.
Biological Chemistry|June 28, 2006
Human tissue kallikrein 9: production of recombinant proteins and specific antibodiesNader Memari, Linda Grass, Terukazu Nakamura, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 12, 2020
Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNAAnnie H Ren, Clare A Fiala, Eleftherios P Diamandis, et al.
Breast Cancer Research and Treatment|January 1, 1994
Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancerM A Levesque, E P Diamandis, H Yu, et al.
British Journal of Cancer|September 1, 1995
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicatorsM A Levesque, G M Clark, H Yu, et al.
Clinical Chemistry|March 1, 1995
Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomyH Yu, E P Diamandis, A F Prestigiacomo, et al.
Molecular & Cellular Proteomics : MCP|April 27, 2012
Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assayAndrei P Drabovich, Maria P Pavlou, Apostolos Dimitromanolakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 26, 2000
Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid glandA Magklara, C C Cheung, S L Asa, et al.
Pageof 79

Showing results (291-300 of 787) with videos related to

Sort By:
Pageof 79
Journal of Proteome Research|June 15, 2007
Proteomic analysis of human cervico-vaginal fluidJulie L V Shaw, Christopher R Smith, Eleftherios P Diamandis
Methods in Molecular Biology (Clifton, N.J.)|April 7, 2011
Immuno-mass spectrometry: quantification of low-abundance proteins in biological fluidsVathany Kulasingam, Christopher R Smith, Ihor Batruch, et al.
Clinical Chemistry|November 2, 1999
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSAA Magklara, A Scorilas, W J Catalona, et al.
Biological Chemistry|June 28, 2006
Human tissue kallikrein 9: production of recombinant proteins and specific antibodiesNader Memari, Linda Grass, Terukazu Nakamura, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 12, 2020
Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNAAnnie H Ren, Clare A Fiala, Eleftherios P Diamandis, et al.
Breast Cancer Research and Treatment|January 1, 1994
Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancerM A Levesque, E P Diamandis, H Yu, et al.
British Journal of Cancer|September 1, 1995
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicatorsM A Levesque, G M Clark, H Yu, et al.
Clinical Chemistry|March 1, 1995
Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomyH Yu, E P Diamandis, A F Prestigiacomo, et al.
Molecular & Cellular Proteomics : MCP|April 27, 2012
Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assayAndrei P Drabovich, Maria P Pavlou, Apostolos Dimitromanolakis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 26, 2000
Expression of prostate-specific antigen and human glandular kallikrein 2 in the thyroid glandA Magklara, C C Cheung, S L Asa, et al.
Pageof 79